Clinical trial
Open-Label,Multicenter Study of G17DT Immunogen in Combination w/ Cisplatin and 5-FU in Subjects w/ Metastatic or Locally Recurrent Gastric or Gastroesophageal Cancer Previously Untreated With Chemotherapy.
NCT00042510 is registered in ClinicalTrials.gov with Cancer Advances Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Open-Label,Multicenter Study of G17DT Immunogen in Combination w/ Cisplatin and 5-FU in Subjects w/ Metastatic or Locally Recurrent Gastric or Gastroesophageal Cancer Previously Untreated With Chemotherapy.
- Lead sponsor
- Cancer Advances Inc.
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- August 31, 2000
- Completion date
- July 31, 2004
- Enrollment
- 103 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.